Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Changes in Skin Color: Clinical Perspectives01:14

Changes in Skin Color: Clinical Perspectives

3.2K
The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
3.2K
Accessory Structures of the Skin: Sebaceous Glands01:21

Accessory Structures of the Skin: Sebaceous Glands

3.6K
A sebaceous gland is a type of oil gland found almost all over the skin ( except palms and soles) and helps lubricate and waterproof the skin and hair. Most sebaceous glands are associated with hair follicles. They generate and excrete sebum, a mixture of lipids, onto the skin surface, thereby naturally lubricating the dry and dead layer of keratinized cells of the stratum corneum, keeping it pliable.
These glands that produce the oils on the skin and hair are holocrine glands. The mature...
3.6K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

161
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
161
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

141
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
141
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

121
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
121
Signs of Puberty01:27

Signs of Puberty

1.1K
Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

Latin America Cutaneous Oncology Management (LACOM) II: A Practical Algorithm for Managing Skin Toxicities in Oncology Patients.

Journal of drugs in dermatology : JDD·2026
Same author

Improvements in clinical and patient-reported outcomes and durability of response with the targeted oral peptide icotrokinra in adolescents with moderate-to-severe plaque psoriasis: One-year results from the ICONIC-LEAD randomized controlled trial.

Journal of the American Academy of Dermatology·2026
Same author

High Curl Pattern Hair and Scalp Care Considerations to Mitigate Seborrheic Dermatitis.

Journal of cosmetic dermatology·2026
Same author

Classification of High Curl Pattern Hair: A Systematic Review and Clinical Perspective.

Journal of cosmetic dermatology·2026
Same author

Pixels, privacy, and permission: Using patient images from social media images for dermatology education.

Journal of the American Academy of Dermatology·2026
Same author

Practical Algorithm for Acne Treatment Integrating Skincare and Energy-Based Devices.

Journal of drugs in dermatology : JDD·2026

Related Experiment Video

Updated: Dec 17, 2025

Author Spotlight: Development and Evaluation of a Compound Acne Rodent Model Using C. acnes and Oleic Acid
03:10

Author Spotlight: Development and Evaluation of a Compound Acne Rodent Model Using C. acnes and Oleic Acid

Published on: November 1, 2024

3.4K

Consensus on Neonatal Through Preadolescent Acne.

Lawrence A. Schachner, Lawrence Eichenfield, Anneke Andriessen

    Journal of Drugs in Dermatology : JDD
    |June 24, 2020
    PubMed
    Summary
    This summary is machine-generated.

    Pediatric acne requires careful attention, with specific age categories defined for diagnosis and management. Healthcare providers should monitor for endocrine issues and consider newer treatments for children over nine.

    More Related Videos

    Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach
    09:32

    Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach

    Published on: September 26, 2019

    7.5K
    Author Spotlight: Advancing Facial Rejuvenation Therapy with Post-Laser Salicylic Acid Application
    03:47

    Author Spotlight: Advancing Facial Rejuvenation Therapy with Post-Laser Salicylic Acid Application

    Published on: September 27, 2024

    1.4K

    Related Experiment Videos

    Last Updated: Dec 17, 2025

    Author Spotlight: Development and Evaluation of a Compound Acne Rodent Model Using C. acnes and Oleic Acid
    03:10

    Author Spotlight: Development and Evaluation of a Compound Acne Rodent Model Using C. acnes and Oleic Acid

    Published on: November 1, 2024

    3.4K
    Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach
    09:32

    Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach

    Published on: September 26, 2019

    7.5K
    Author Spotlight: Advancing Facial Rejuvenation Therapy with Post-Laser Salicylic Acid Application
    03:47

    Author Spotlight: Advancing Facial Rejuvenation Therapy with Post-Laser Salicylic Acid Application

    Published on: September 27, 2024

    1.4K

    Area of Science:

    • Dermatology
    • Pediatrics

    Background:

    • Pediatric acne, a common dermatological issue, can manifest from infancy and requires age-specific categorization.
    • It may indicate underlying pathologies, necessitating vigilant monitoring in children.

    Framework:

    • An expert panel developed consensus statements on neonatal through preadolescent acne.
    • A systematic literature review informed the consensus on diagnosis, prevention, and treatment.

    Implementation:

    • Seven consensus statements were established, defining pediatric acne by age: neonatal (birth-8 weeks), infantile (8 weeks-1 year), mid-childhood (1-7 years), preadolescent (7-12 years), and adolescent (12-19 years).
    • Emphasis is placed on monitoring for endocrine-associated abnormalities, particularly in mid-childhood acne.

    Implications:

    • Healthcare providers need increased awareness of pediatric acne's differential diagnosis and management.
    • Newer medications approved for children over nine offer potential treatment options.